ResonanceDx Inc. is an early stage medical
diagnostic start-up and is commercializing rapid easy to use diagnostic tests
based on antibody-antigen reactions that are quantified via wafer fabricated
acoustic resonating sensors. John Ashley, the CEO, shares his perspective
on the value of SENIC user facility to his company.